Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020;395(10223):470-3.

Organization WH. Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020. 2020.

Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. European Journal of Clinical Microbiology & Infectious Diseases. 2021;40(1):13-25.

Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of medical virology. 2020;92(7):797-806.

WHO. WHO Coronavirus (COVID-19) Dashboard https://covid19.who.int/ [

Chakraborty R, Parvez S. COVID-19: An overview of the current pharmacological interventions, vaccines, and clinical trials. Biochemical pharmacology. 2020:114184.

Saeed BQ, Al-Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side Effects and Perceptions Following Sinopharm COVID-19 Vaccination. International Journal of Infectious Diseases. 2021.

Zhang Y, Zeng G, Pan H, Li Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The lancet. 2020;395(10223):470-3. doi: 10.1016/S0140-6736(20)30185-9. [PubMed: 31986257]

Organization WH. Naming the coronavirus disease (COVID-19) and the virus that causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it. 2020.

Dao TL, Hoang VT, Gautret P. Recurrence of SARS-CoV-2 viral RNA in recovered COVID-19 patients: a narrative review. Eur J Clin Microbiol Infect Dis. 2021;40(1):13-25. doi: 10.1007/s10096-020-04088-z. [PubMed: 33113040]

Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID‐19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797-806. doi: 10.1002/jmv.25783. [PubMed: 32198776]

WHO. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. 2022.

Chakraborty R, Parvez S. COVID-19: an overview of the current pharmacological interventions, vaccines, and clinical trials. Biochem Pharmacol. 2020;180:1-17. doi: 10.1016/j.bcp.2020.114184. [PubMed: 32739342]

Saeed BQ, Al Shahrabi R, Alhaj SS, Alkokhardi ZM, Adrees AO. Side effects and perceptions following sinopharm COVID-19 vaccination. Int J Infect Dis. 2021;111:219-26. doi: 10.1016/j.ijid.2021.08.013. [PubMed: 34384899]

Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis.

;21(2):181-92. doi: 10.1016/S1473-3099(20)30843-4. [PubMed: 33217362]

Reported Cases and Deaths by Country or Territory. worldometer. https://www.worldometers.info/coronavirus/. 2022.

Baraniuk C. What do we know about China’s covid-19 vaccines?. BMJ. 2021;373:912. doi: 10.1136/bmj.n912. [PubMed: 33836994]

Organization WH. Evidence Assessment: Sinopharm/BBIBP COVID-19 vaccine. 2021.

online: GTC-S-DDTA. Gender and sex-disaggregated data for COVID-19 e: https://globalhealth5050.org/wp-content /uploads/December-2020-The-COVID-19-Sex-Disaggregated-Data-Tracker-Update. 2020.

Kovats S, Carreras E, Agrawal H. Sex steroid receptors in immune cells. Sex hormones and immunity to infection: Springer; 2010.

Di Resta C, Ferrari D, Vigano M, Moro M, Sabetta E, Minerva M, et al. The gender impact assessment among healthcare workers in the SARS-CoV-2 vaccination-an analysis of serological response and side effects. Vaccines (Basel). 2021;9(5):1-13. doi: 10.3390/vaccines9050522. [PubMed: 34070196]

Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, et al. Safety of COVID‐19 vaccines. J Med Virol. 2021;93(12):6588-94. doi: 10.1002/jmv.27214. [PubMed: 34270094]

Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, et al. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology (Basel). 2021;10(8):1-21. doi: 10.3390/biology10080752. [PubMed: 34439984]

Riad A, Pokorna A, Attia S, Klugarova J, Koscik M, Klugar M. Prevalence of COVID-19 Vaccine side effects among healthcare workers in the czech republic. J Clin Med. 2021;10(7):1-18. doi: 10.3390/jcm10071428. [PubMed: 33916020]

Almufty HB, Mohammed SA, Abdullah AM, Merza MA. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab Syndr. 2021;15(5):102207. doi: 10.1016/j.dsx.2021.102207. [PubMed: 34280733]

Jarynowski A, Semenov A, Kaminski M, Belik V. Mild adverse events of sputnik v vaccine extracted from russian language telegram posts via BERT deep learning model. J Med Internet Res. 2021;23(11):30529. doi: 10.2196/30529. [PubMed: 34662291]

Abu Hammad O, Alduraidi H, Abu Hammad S, Alnazzawi A, Babkair H, Abu Hammad A, et al. Side effects reported by jordanian healthcare workers who received COVID-19 vaccines. Vaccines (Basel). 2021;9(6):1-10. doi: 10.3390/vaccines9060577. [PubMed: 34205917]

Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(5):338-49. doi: 10.1016/S1473-3099(10)70049-9. [PubMed: 20417416]

Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. J Infect Dis. 2014;209(3):114-9. doi: 10.1093/infdis/jiu066. [PubMed: 24966191]

Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1. [PubMed: 33306989]

Athavale AV. The Covid-19 Vaccine. J adv res med sci technol. 2021;8(1):29-35. doi: 0000-0002-8207-9589.

Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, et al. Self-reported real-world safety and reactogenicity of covid-19 vaccines: A vaccine recipient survey. Life (Basel). 2021;11(3):249. doi: 10.3390/life11030249. [PubMed: 33803014]

Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020;395(10240):1845-54. doi: 10.1016/S0140-6736(20)31208-3. [PubMed: 32450106]

Kadali RAK, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. Int J Infect Dis. 2021;106:376-81. doi: 10.1016/j.ijid.2021.04.047. [PubMed: 33866000]

C, Hu Y, Chu K, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. The Lancet infectious diseases. 2021;21(2):181-92.

Reported Cases and Deaths by Country or Territory: worldometer; 2022 [Available from: https://www.worldometers.info/coronavirus/.

Baraniuk C. What do we know about China’s covid-19 vaccines? bmj. 2021;373:912.

Organization WH. Evidence Assessment: Sinopharm/BBIBP COVID-19 vaccine. 2021.

online: GTC-S-DDTA. Gender and sex-disaggregated data for COVID-19 e: https://globalhealth5050.org/wp-content/

uploads/December-2020-The-COVID-19-Sex-Disaggregated-Data-Tracker-Update.pdf2020 [

Kovats S, Carreras E, Agrawal H. Sex steroid receptors in immune cells. Sex hormones and immunity to infection: Springer; 2010. p. 53-91.

Di Resta C, Ferrari D, Viganò M, Moro M, Sabetta E, Minerva M, et al. The Gender Impact Assessment among Healthcare Workers in the SARS-CoV-2 Vaccination—An Analysis of Serological Response and Side Effects. Vaccines. 2021;9(5):522.

Al Khames Aga QA, Alkhaffaf WH, Hatem TH, Nassir KF, Batineh Y, Dahham AT, et al. Safety of COVID‐19 vaccines. Journal of medical virology. 2021.

Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt H-P, et al. Side effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers. Biology. 2021;10(8):752.

Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic. Journal of Clinical Medicine. 2021;10(7):1428.

Almufty HB, Mohammed SA, Abdullah AM, Merza MA. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(5):102207.

Jarynowski A, Semenov A, Kaminski M, Belik V. Mild Adverse Events of Sputnik V Vaccine Extracted from Russian Language Telegram Posts via BERT Deep Learning Model. medRxiv. 2021.

Abu-Hammad O, Alduraidi H, Abu-Hammad S, Alnazzawi A, Babkair H, Abu-Hammad A, et al. Side Effects Reported by Jordanian Healthcare Workers Who Received COVID-19 Vaccines. Vaccines. 2021;9(6):577.

Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. The Lancet infectious diseases. 2010;10(5):338-49.

Klein SL, Pekosz A. Sex-based biology and the rational design of influenza vaccination strategies. The Journal of infectious diseases. 2014;209(suppl_3):S114-S9.

Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 2021;397(10269):99-111.

Athavale AV. The Covid-19 Vaccine. Journal of Advanced Research in Medical Science & Technology (ISSN: 2394-6539). 2021;8(1):29-35.

Mathioudakis AG, Ghrew M, Ustianowski A, Ahmad S, Borrow R, Papavasileiou LP, et al. Self-reported real-world safety and reactogenicity of covid-19 vaccines: A vaccine recipient survey. Life. 2021;11(3):249.

Zhu F-C, Li Y-H, Guan X-H, Hou L-H, Wang W-J, Li J-X, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. The Lancet. 2020;395(10240):1845-54.

Kadali RA, Janagama R, Peruru S, Malayala SV. Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers. International Journal of Infectious Diseases. 2021;106:376-81.